Gw Henssler & Associates LTD Orgenesis Inc. Transaction History

Gw Henssler & Associates LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$2.61 - $4.9 $28,710 - $53,900	-11,000 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$4.77 - $8.08 $52,469 - $88,880	11,000 New	11,000 $63,000
Q4 2020 Feb 02, 2021	SELL	$4.4 - $5.63 $48,400 - $61,930	-11,000 Closed	0 $0
Q4 2018 Jan 22, 2019	BUY	$3.88 - $7.46 $42,680 - $82,060	11,000 New	11,000 $51,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Gw Henssler & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on Gw Henssler & Associates LTD with notifications on news.